Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels
Abstract Background Alzheimer’s disease (AD) has been associated with immune dysregulation in biomarker and genome-wide association studies (GWAS). GWAS hits include the genes encoding complement regulators clusterin (CLU) and complement receptor 1 (CR1), recognised as key players in AD pathology, a...
Main Authors: | Aurora Veteleanu, Joshua Stevenson-Hoare, Samuel Keat, Nikoleta Daskoulidou, Henrik Zetterberg, Amanda Heslegrave, Valentina Escott-Price, Julie Williams, Rebecca Sims, Wioleta M. Zelek, Sarah M. Carpanini, Bryan Paul Morgan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12974-023-02850-6 |
Similar Items
-
Genetic Insights into the Impact of Complement in Alzheimer’s Disease
by: Megan Torvell, et al.
Published: (2021-12-01) -
The Impact of Complement Genes on the Risk of Late-Onset Alzheimer’s Disease
by: Sarah M. Carpanini, et al.
Published: (2021-03-01) -
Complement C7 and clusterin form a complex in circulation
by: Mariam Massri, et al.
Published: (2024-01-01) -
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
by: Sarah M. Carpanini, et al.
Published: (2022-07-01) -
Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System
by: Sarah M. Carpanini, et al.
Published: (2019-03-01)